CTI BioPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Property, Plant & Equipment	19,017	18,794	18,395	13,731	12,687	-
Cash & Equivalents	77.01	215.06	1,317	147.23	240.53	3,111
Accounts Receivable	28.76	35.26	35.51	22.01	24.21	13.64
Investment In Debt and Equity Securities	3,210	3,474	2,686	2,387	2,438	297.11
Other Current Assets	242.25	23.78	19.08	12.36	7.05	2.47
Deferred Long-Term Charges	-	-	0.84	5.77	7.02	-
Other Long-Term Assets	-	-	99.29	52.71	279.49	7,166
Total Assets	22,576	22,542	22,552	16,359	15,682	10,590
Current Portion of Long-Term Debt	-	-	5,286	-	-	-
Long-Term Debt	5,196	5,196	-	5,336	4,821	-
Accrued Expenses	21.46	15.87	20.95	11.24	10.99	2.8
Current Income Taxes Payable	5.12	15.66	12.87	12.08	11.19	0.43
Current Unearned Revenue	1.17	1.13	5.69	0.73	0.28	0.26
Other Current Liabilities	16.47	21.4	16.34	-	5.86	75.5
Other Long-Term Liabilities	71.11	68.35	68.02	37.71	29.78	1.58
Total Liabilities	5,311	5,318	5,410	5,398	4,879	80.57
Common Stock	16,582	16,582	16,582	10,582	10,582	10,582
Retained Earnings	290.52	299.09	206.7	243.43	219.41	-72.44
Comprehensive Income & Other	392.28	342.81	353.64	135.68	1.95	0.09
Shareholders' Equity	17,265	17,224	17,142	10,961	10,803	10,509
Total Liabilities & Equity	22,576	22,542	22,552	16,359	15,682	10,590
Total Debt	5,196	5,196	5,286	5,336	4,821	-
Net Cash (Debt)	-5,119	-4,981	-3,969	-5,189	-4,581	3,111
Net Cash Per Share	-3.09	-3.00	-2.39	-4.90	-4.33	2.94
Filing Date Shares Outstanding	1,658	1,658	1,658	1,058	1,058	1,058
Total Common Shares Outstanding	1,658	1,658	1,658	1,058	1,058	1,058
Book Value Per Share	10.41	10.39	10.34	10.36	10.21	9.93
Tangible Book Value	17,265	17,224	17,142	10,961	10,803	10,509
Tangible Book Value Per Share	10.41	10.39	10.34	10.36	10.21	9.93

Updated Aug 17, 2023. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.